About G-protein coupled bile acid receptor 1
G-protein coupled bile acid receptor 1 (GPBAR1) is a protein
from Homo sapiens identified by UniProt accession
Q8TDU6, 330 residues long.
MolForge cross-references it against 0 known binders and
334 disease associations.
Target properties
| Protein name | G-protein coupled bile acid receptor 1 |
| UniProt accession | Q8TDU6 |
| Gene | GPBAR1 |
| Organism | Homo sapiens |
| Length | 330 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (7)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (334)
Diseases linked to this target (Open Targets).
- Red cell distribution width · score 0.27
- monocyte count · score 0.25
- neutrophil count · score 0.23
- glioblastoma multiforme · score 0.23
- leukocyte count · score 0.21
- cholelithiasis · score 0.18
- vital capacity · score 0.18
- gallbladder disease · score 0.18
- reticulocyte count · score 0.18
- biliary tract disease · score 0.17
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8TDU6-F1 | alphafold | PREDICTED | 80.42 | — |
Amino-acid sequence (330 residues)
MTPNSTGEVP SPIPKGALGL SLALASLIIT ANLLLALGIA WDRRLRSPPA GCFFLSLLLA GLLTGLALPT LPGLWNQSRR GYWSCLLVYL APNFSFLSLL ANLLLVHGER YMAVLRPLQP PGSIRLALLL TWAGPLLFAS LPALGWNHWT PGANCSSQAI FPAPYLYLEV YGLLLPAVGA AAFLSVRVLA TAHRQLQDIC RLERAVCRDE PSALARALTW RQARAQAGAM LLFGLCWGPY VATLLLSVLA YEQRPPLGPG TLLSLLSLGS ASAAAVPVAM GLGDQRYTAP WRAAAQRCLQ GLWGRASRDS PGPSIAYHPS SQSSVDLDLN
Explore G-protein coupled bile acid receptor 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets